Skip to content

Author

M. Alnees

We have 3 of 65 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Clinical outcomes associated with glucagon-like peptide-1 receptor agonist therapy in patients with peripheral artery disease and diabetes.

AIM Peripheral artery disease (PAD) and diabetes are associated with high risks of limb complications and mortality. Although glucagon-like peptide-1 receptor agonists (GLP1-RAs) improve cardiovascular outcomes, their effect on limb outcomes in PAD remains uncertain. METHODS We conducted a retrospective cohort study...

H. A. Khadija, M. Alnees, Ali Abdullah et al. · 0 citations
Open access Aug 2026

A novel composite inflammatory–metabolic index for long-term prognosis after TAVR: the modifying role of left ventricular ejection fraction

Background Metabolic dysfunction and systemic inflammation are increasingly recognized as important determinants of outcomes after transcatheter aortic valve replacement (TAVR). However, whether their prognostic impact differs according to baseline left ventricular systolic function remains unclear. Objectives To evalu...

Haitham Abu Khadija, Nizar Abu Hamdeh, D. Najajra et al. · 0 citations
Open access Aug 2026

CT-based multi-threshold calcium scoring for aortic valve assessment: comparable predictive performance across HU thresholds in a pre-TAVI cohort.

Higher HU thresholds did not outperform conventional 130-HU scoring and showed only modest, comparable performance for within-severity hemodynamic stratification, and should be interpreted as complementary densitometric analyses rather than alternative diagnostic cut-offs.

Michael Welt, M. Alnees, Yazan Hamdan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.